Overview
- DR Congo’s confirmed toll has climbed to about 3,262 cases and 1,437 deaths, a rapid rise that in roughly ten weeks has brought the outbreak close to the size of the country’s 2018–2020 epidemic.
- The outbreak is driven by the rare Bundibugyo Ebola virus, for which no approved vaccine or specific treatment exists, prompting emergency trials rather than ready-to-deploy countermeasures.
- Response work is being disrupted by violence, attacks on health facilities and strikes by unpaid health workers, with frontline teams reporting shortages of vehicles, phone credit and trained investigators.
- Surveillance limits are severe: WHO says the true number of infections could be two to four times higher, and humanitarian groups report roughly 80% of new cases are detected outside known contact lists.
- Researchers have begun clinical studies, including the University of Oxford’s first human vaccine dosing and treatment trials for candidate drugs, but officials warn results and broad deployment will take months while cross-border risk remains real as neighbouring Uganda has just declared its outbreak over.